Exploring the intricate landscape of cardiac lipidomics, this dynamic field delves into the intricate world of lipid molecules within the cardiovascular system. As crucial components of cell membranes, lipids play an essential role in shaping cellular structure and functionality. In the realm of cardiac health, lipidomics extends its reach to comprehensively study the lipid composition of cardiac tissues, shedding light on their multifaceted roles in both physiological equilibrium and pathological disruptions. By unraveling the complexities of the heart's lipidomic profile, researchers gain valuable insights into lipid metabolism, signaling pathways, and their implications for various cardiac conditions, ranging from atherosclerosis to heart failure. Utilizing cutting-edge analytical techniques, experts in cardiac lipidomics strive to characterize diverse lipid species, opening avenues for innovative diagnostic tools and therapeutic interventions to tackle cardiovascular disorders. This fusion of lipid biochemistry and cardiology not only offers a deeper understanding of cardiac lipidomics but also holds the potential to uncover novel biomarkers and therapeutic targets, fostering advancements in cardiovascular medicine.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation